Target intelligence / Profile preview

von Willebrand factor A domain-containing protein 1 (VWA1)

Target
VWA1
Molecular classification
Other (extracellular matrix protein), Fibronectin type III domain-containing protein
01

Overview

The von Willebrand factor A domain-containing protein 1 (VWA1) is an extracellular matrix protein that belongs to the von Willebrand factor A (VWFA) domain superfamily. It is also known as WARP and is characterized by its high-affinity binding to structural extracellular proteins such as collagen VI and perlecan. VWA1 is predominantly expressed in muscle and peripheral nerve tissues, where it plays a crucial role in maintaining neuromuscular structure and the assembly of the pericellular matrix. Loss-of-function mutations in the VWA1 gene are linked to neuromuscular disorders marked by muscle weakness as well as contributions to congenital craniofacial disorders such as hemifacial microsomia. While VWA1 is structurally and functionally significant in extracellular matrix biology and tissue stability, there are no current indications that it acts as a direct therapeutic target, nor are there approved drugs specifically targeting this protein[2][4][6].

Other names
FLJ22215WARPHMNMYOHMNR74932416A11RIKvon Willebrand factor A domain-related protein
02

Biological functions

Extracellular matrix organizationMaintenance of neuromuscular structuresProtein–protein interactions (collagen VI and perlecan)Stabilization of tissue microenvironments
03

Disease associations

Neuromyopathic disorder (e.g., muscle weakness due to biallelic loss-of-function variants)Hemifacial microsomia (HFM, as shown in genetic studies)Structural and developmental disorders involving cartilage and connective tissue

Beyond the preview

Go deeper on von Willebrand factor A domain-containing protein 1 (VWA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on von Willebrand factor A domain-containing protein 1 (VWA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call